MarketLens
Sign Up

Thermo Fisher's Executive Sales: A Calculated Monetization Amidst Strong Performance

2 months ago
SHARE THIS ON:

Thermo Fisher's Executive Sales: A Calculated Monetization Amidst Strong Performance

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•2 months ago

Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg

Thermo Fisher Scientific completed the sale of its microbiology business to Astorg for ~$1.075 billion in cash and a $50 million seller note, after the divestiture of its antimicrobial susceptibility ...
Stock News•2 months ago

Thermo Fisher Raises 2026 Outlook After Strong Second-Quarter Results

Thermo Fisher raised its 2026 outlook after Q2 earnings and revenue beat expectations, citing stronger customer activity, better acquisition performance, and improved operating leverage.
Stock News•2 months ago

Acumen Wealth Advisors LLC Sells 2,166 Shares of Thermo Fisher Scientific Inc. $TMO

Acumen Wealth Advisors cut its Thermo Fisher Scientific holdings by 14.7% in Q1, selling 2,166 shares to 12,562, per a 13F filing.

Breaking News

View All →

No topics available at the moment

Top Headlines

View More →
Stock News•54 minutes ago

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG

Stock News•1 hour ago

Why the Market Dipped But Meta Platforms (META) Gained Today

Stock News•1 hour ago

Nvidia in 5 Years: Where the Stock Could Be Headed

Stock News•2 hours ago

UK finance minister Healey to target online marketplaces in tax crackdown, The Times reports

Stock News•2 hours ago

Character.AI owes Google and Big Law firms nearly $7M, court filings show